Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Larimar Therapeutics, Inc. | lrmr-ex321_6.htm |
| EX-31.2 - EX-31.2 - Larimar Therapeutics, Inc. | lrmr-ex312_8.htm |
| EX-31.1 - EX-31.1 - Larimar Therapeutics, Inc. | lrmr-ex311_7.htm |
| EX-21.1 - EX-21.1 - Larimar Therapeutics, Inc. | lrmr-ex211_408.htm |
| EX-4.2 - EX-4.2 - Larimar Therapeutics, Inc. | lrmr-ex42_407.htm |
| 10-K - 10-K - Larimar Therapeutics, Inc. | lrmr-10k_20201231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-239510, 333-246370, and 333-228328) and Form S-8 (Nos. 333-239509 and 333-249287) of Larimar Therapeutics, Inc. of our report dated March 4, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 4, 2021
1